Novartis Investigative Site is a clinical research site located in Bangor, Maine, United States 04401.
Crixeo Health Trust Score: 73/100 (FAIR). This profile has not yet been claimed by the site owner.
Novartis Investigative Site has participated in 17 clinical trials.
Therapeutic areas: Chronic Spontaneous Urticaria, Asthma, Chronic Obstructive Pulmonary Disease (COPD).
Sponsors: Novartis Pharmaceuticals, Novartis.
Trust Score: 73/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Novartis Investigative Site has a Crixeo Trust Score of 73/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Novartis Investigative Site has 17 clinical trials on record. Their work covers Chronic Spontaneous Urticaria, Asthma, Chronic Obstructive Pulmonary Disease (COPD).
Novartis Investigative Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.